AdvanSix Q4 Sales Rise 9% to $359.9M but EPS Misses Estimates
AdvanSix reported Q4 sales of $359.9 million, a 9% increase driven by an 11% volume rise in its Plant Nutrients segment, while adjusted EBITDA jumped to $24.8 million from $10.2 million. Adjusted EPS fell to $0.03, well below the $0.43 consensus, as GAAP EPS was a $0.10 loss.
1. Q4 Sales Performance
AdvanSix achieved Q4 sales of $359.9 million, up 9% from $329.1 million in Q4 2024, driven by an 11% volume increase and favorable pricing in its Plant Nutrients segment.
2. Earnings Results
GAAP EPS was a $0.10 loss, while adjusted EPS came in at $0.03, significantly below the $0.43 analyst consensus and down from $0.09 a year earlier, reflecting ongoing pricing pressures.
3. Cash Flow and EBITDA
Adjusted EBITDA rose to $24.8 million from $10.2 million, expanding margins to 6.9% from 3.1% as plant utilization improved; operating cash flow totaled $63.7 million and free cash flow reached $36.1 million.
4. 2026 Outlook and Dividend
For full-year 2025, AdvanSix generated $1.52 billion in sales, $49.3 million in net income and $156.8 million in adjusted EBITDA; management forecasts 2026 capital expenditures of $75–95 million and expects cash flow benefits from 45Q carbon capture tax credits and bonus depreciation, while paying a $0.16 quarterly dividend per share.